XML 79 R69.htm IDEA: XBRL DOCUMENT v3.19.1
Schedule Of Other Derivatives Not Designated As Hedging Instruments Statements OfFinancial Performance And Financial Position Location (Details) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Net Revenues [Member] | Not Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Gain (Loss) on Derivative Instruments, Net, Pretax $ 4,295 $ 5,065
Net Revenues [Member] | Not Designated as Hedging Instrument, Trading [Member]    
Derivative [Line Items]    
Gain (Loss) on Derivative Instruments, Net, Pretax [1] 0 0
Financial expenses [Member] | Not Designated as Hedging Instrument [Member]    
Derivative [Line Items]    
Gain (Loss) on Derivative Instruments, Net, Pretax 218 271
Financial expenses [Member] | Not Designated as Hedging Instrument, Trading [Member]    
Derivative [Line Items]    
Gain (Loss) on Derivative Instruments, Net, Pretax [1] $ (42) $ 19
[1] Teva uses foreign exchange contracts (mainly option and forward contracts) to hedge balance sheet items from currency exposure. These foreign exchange contracts are not designated as hedging instruments for accounting purposes. In connection with these foreign exchange contracts, Teva recognizes gains or losses that offset the revaluation of the balance sheet items also recorded under financial expenses—net.